Sarcoma Patients EuroNet has established an Medical Advisory Board with a high level of scientific expertise. The objectives of the Medical Advisory Board is to support SPAEN in:

• gaining legitimacy within the European and International community of experts involved in Sarcoma, GIST and desmoïd tumours;

• ensuring patient representation in, and integration to, major scientific committees and groups of experts at national and European levels.

The following 14 experts are appointed as members of the SPAEN Medical Advisory Board (2010 - 2013):

Prof. Dr. Jean Yes Blay (EORTC President and Director of Conticanet) who is chair of the SPAEN Medical Advisory Board states: “Sarcoma Patients EuroNet is a very welcome development. We need to involve patients in clinical trials at the design stage so that the relevance of what we do can be considered at the outset. In addition SPAEN will be valuable helping patients understand what being treated in a clinical trial could mean to them. Together we can complete research more quickly and introduce new treatments faster.”